Christopher Richard Anzalone - Net Worth and Insider Trading
Christopher Richard Anzalone Net Worth
The estimated net worth of Christopher Richard Anzalone is at least $76 Million dollars as of 2024-11-05. Christopher Richard Anzalone is the CEO of Arrowhead Pharmaceuticals Inc and owns about 3,715,048 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $76 Million. Details can be seen in Christopher Richard Anzalone's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Richard Anzalone has not made any transactions after 2024-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Richard Anzalone
Christopher Richard Anzalone Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Richard Anzalone owns 1 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) .
Click here to see the complete history of Christopher Richard Anzalone’s form 4 insider trades.
Insider Ownership Summary of Christopher Richard Anzalone
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-31 | director & President and CEO |
Christopher Richard Anzalone Latest Holdings Summary
Christopher Richard Anzalone currently owns a total of 1 stock. Christopher Richard Anzalone owns 3,715,048 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 31, 2024, with a value of $76 Million.
Latest Holdings of Christopher Richard Anzalone
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2024-01-31 | 3,715,048 | 20.44 | 75,935,581 |
Holding Weightings of Christopher Richard Anzalone
Christopher Richard Anzalone Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Richard Anzalone has made a total of 16 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 57,499 shares on January 31, 2024, which brought Christopher Richard Anzalone around $2 Million.
Insider Trading History of Christopher Richard Anzalone
- 1
Christopher Richard Anzalone Trading Performance
Christopher Richard Anzalone Ownership Network
Ownership Network List of Christopher Richard Anzalone
Ownership Network Relation of Christopher Richard Anzalone
Christopher Richard Anzalone Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Christopher Richard Anzalone is the director & President and CEO of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Christopher Richard Anzalone made 5 insider transaction in Arrowhead Pharmaceuticals Inc (ARWR) with a net sale of 161,544. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 55,383 shares made by James C Hamilton , a net sale of 71,104 shares made by Kenneth Allen Myszkowski , and a net sale of 18,393 shares made by Tracie Oliver .
In summary, during the past 3 months, insiders sold 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,678 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 382,678 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Christopher Richard Anzalone Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Richard Anzalone. You might contact Christopher Richard Anzalone via mailing address: Arrowhead Research Corporation, 201 South Lake Avenue, Suite 703, Pasadena Ca 91101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
